How big is the gene therapy on neurological diseases market?

In the future this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery.Market Analysis and Insights Global Gene Therapy on Neurological Diseases MarketIn 2021 the global Gene Therapy on Neurological Diseases market size will be US million and it is expected to reach US million by the end of 2027 with a CAGR of during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy on Neurological Diseases market to help players in achieving a strong market position.

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2028

Code: QYRE-Auto-25M7562

Report

March 2022

Pages:73

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Biogen

Novartis

Sarepta Therapeutics

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Market Analysis and Insights: Global Gene Therapy on Neurological Diseases Market

The global Gene Therapy on Neurological Diseases market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Viral Gene Therapy accounting for % of the Gene Therapy on Neurological Diseases global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Gene Therapy on Neurological Diseases market size is valued at US$ million in 2021, while the North America and Europe Gene Therapy on Neurological Diseases are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Gene Therapy on Neurological Diseases landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy on Neurological Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy on Neurological Diseases market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy on Neurological Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy on Neurological Diseases market.

Global Gene Therapy on Neurological Diseases Scope and Market Size

Gene Therapy on Neurological Diseases market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gene Therapy on Neurological Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Segment by Application

Hospital

Clinic

Other

BY COMPANY

Biogen

Novartis

Sarepta Therapeutics

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Biogen

Novartis

Sarepta Therapeutics

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Viral Gene Therapy

1.2.3 Non-viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2017-2028)

2.2 Gene Therapy on Neurological Diseases Growth Trends by Region

2.2.1 Gene Therapy on Neurological Diseases Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Gene Therapy on Neurological Diseases Historic Market Size by Region (2017-2022)

2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2023-2028)

2.3 Gene Therapy on Neurological Diseases Market Dynamics

2.3.1 Gene Therapy on Neurological Diseases Industry Trends

2.3.2 Gene Therapy on Neurological Diseases Market Drivers

2.3.3 Gene Therapy on Neurological Diseases Market Challenges

2.3.4 Gene Therapy on Neurological Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue

3.1.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue (2017-2022)

3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2017-2022)

3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy on Neurological Diseases Revenue

3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio

3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2021

3.5 Gene Therapy on Neurological Diseases Key Players Head office and Area Served

3.6 Key Players Gene Therapy on Neurological Diseases Product Solution and Service

3.7 Date of Enter into Gene Therapy on Neurological Diseases Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy on Neurological Diseases Breakdown Data by Type

4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2017-2022)

4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2023-2028)

5 Gene Therapy on Neurological Diseases Breakdown Data by Application

5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2017-2022)

5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Gene Therapy on Neurological Diseases Market Size (2017-2028)

6.2 North America Gene Therapy on Neurological Diseases Market Size by Type

6.2.1 North America Gene Therapy on Neurological Diseases Market Size by Type (2017-2022)

6.2.2 North America Gene Therapy on Neurological Diseases Market Size by Type (2023-2028)

6.2.3 North America Gene Therapy on Neurological Diseases Market Share by Type (2017-2028)

6.3 North America Gene Therapy on Neurological Diseases Market Size by Application

6.3.1 North America Gene Therapy on Neurological Diseases Market Size by Application (2017-2022)

6.3.2 North America Gene Therapy on Neurological Diseases Market Size by Application (2023-2028)

6.3.3 North America Gene Therapy on Neurological Diseases Market Share by Application (2017-2028)

6.4 North America Gene Therapy on Neurological Diseases Market Size by Country

6.4.1 North America Gene Therapy on Neurological Diseases Market Size by Country (2017-2022)

6.4.2 North America Gene Therapy on Neurological Diseases Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Gene Therapy on Neurological Diseases Market Size (2017-2028)

7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type

7.2.1 Europe Gene Therapy on Neurological Diseases Market Size by Type (2017-2022)

7.2.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2023-2028)

7.2.3 Europe Gene Therapy on Neurological Diseases Market Share by Type (2017-2028)

7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application

7.3.1 Europe Gene Therapy on Neurological Diseases Market Size by Application (2017-2022)

7.3.2 Europe Gene Therapy on Neurological Diseases Market Size by Application (2023-2028)

7.3.3 Europe Gene Therapy on Neurological Diseases Market Share by Application (2017-2028)

7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country

7.4.1 Europe Gene Therapy on Neurological Diseases Market Size by Country (2017-2022)

7.4.2 Europe Gene Therapy on Neurological Diseases Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2017-2028)

8.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type

8.2.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Type (2017-2028)

8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application

8.3.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Application (2017-2028)

8.4 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region

8.4.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Gene Therapy on Neurological Diseases Market Size (2017-2028)

9.2 Latin America Gene Therapy on Neurological Diseases Market Size by Type

9.2.1 Latin America Gene Therapy on Neurological Diseases Market Size by Type (2017-2022)

9.2.2 Latin America Gene Therapy on Neurological Diseases Market Size by Type (2023-2028)

9.2.3 Latin America Gene Therapy on Neurological Diseases Market Share by Type (2017-2028)

9.3 Latin America Gene Therapy on Neurological Diseases Market Size by Application

9.3.1 Latin America Gene Therapy on Neurological Diseases Market Size by Application (2017-2022)

9.3.2 Latin America Gene Therapy on Neurological Diseases Market Size by Application (2023-2028)

9.3.3 Latin America Gene Therapy on Neurological Diseases Market Share by Application (2017-2028)

9.4 Latin America Gene Therapy on Neurological Diseases Market Size by Country

9.4.1 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2017-2022)

9.4.2 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2017-2028)

10.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type

10.2.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Type (2017-2028)

10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application

10.3.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Application (2017-2028)

10.4 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country

10.4.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction

11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2017-2022)

11.1.5 Biogen Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction

11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2017-2022)

11.2.5 Novartis Recent Developments

11.3 Sarepta Therapeutics

11.3.1 Sarepta Therapeutics Company Details

11.3.2 Sarepta Therapeutics Business Overview

11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction

11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2017-2022)

11.3.5 Sarepta Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Biogen

Novartis

Sarepta Therapeutics

List of Tables

Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Viral Gene Therapy

Table 3. Key Players of Non-viral Gene Therapy

Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Gene Therapy on Neurological Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2017-2022)

Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2023-2028)

Table 10. Gene Therapy on Neurological Diseases Market Trends

Table 11. Gene Therapy on Neurological Diseases Market Drivers

Table 12. Gene Therapy on Neurological Diseases Market Challenges

Table 13. Gene Therapy on Neurological Diseases Market Restraints

Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Gene Therapy on Neurological Diseases Revenue Share by Players (2017-2022)

Table 16. Global Top Gene Therapy on Neurological Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2021)

Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Gene Therapy on Neurological Diseases Product Solution and Service

Table 21. Date of Enter into Gene Therapy on Neurological Diseases Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2017-2022)

Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2023-2028)

Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Gene Therapy on Neurological Diseases Revenue Share by Application (2017-2022)

Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Gene Therapy on Neurological Diseases Revenue Share by Application (2023-2028)

Table 31. North America Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Gene Therapy on Neurological Diseases Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Gene Therapy on Neurological Diseases Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Gene Therapy on Neurological Diseases Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Gene Therapy on Neurological Diseases Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Gene Therapy on Neurological Diseases Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Gene Therapy on Neurological Diseases Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Gene Therapy on Neurological Diseases Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Gene Therapy on Neurological Diseases Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Gene Therapy on Neurological Diseases Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Gene Therapy on Neurological Diseases Market Size by Country (2023-2028) & (US$ Million)

Table 61. Biogen Company Details

Table 62. Biogen Business Overview

Table 63. Biogen Gene Therapy on Neurological Diseases Product

Table 64. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2017-2022) & (US$ Million)

Table 65. Biogen Recent Developments

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Gene Therapy on Neurological Diseases Product

Table 69. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2017-2022) & (US$ Million)

Table 70. Novartis Recent Developments

Table 71. Sarepta Therapeutics Company Details

Table 72. Sarepta Therapeutics Business Overview

Table 73. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product

Table 74. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2017-2022) & (US$ Million)

Table 75. Sarepta Therapeutics Recent Developments

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Therapy on Neurological Diseases Market Share by Type: 2021 VS 2028

Figure 2. Viral Gene Therapy Features

Figure 3. Non-viral Gene Therapy Features

Figure 4. Global Gene Therapy on Neurological Diseases Market Share by Application: 2021 VS 2028

Figure 5. Hospital Case Studies

Figure 6. Clinic Case Studies

Figure 7. Other Case Studies

Figure 8. Gene Therapy on Neurological Diseases Report Years Considered

Figure 9. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Gene Therapy on Neurological Diseases Market Share by Region: 2021 VS 2028

Figure 12. Global Gene Therapy on Neurological Diseases Market Share by Players in 2021

Figure 13. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2021

Figure 15. North America Gene Therapy on Neurological Diseases Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2028)

Figure 17. North America Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2028)

Figure 18. North America Gene Therapy on Neurological Diseases Market Size Share by Country (2017-2028)

Figure 19. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Gene Therapy on Neurological Diseases Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2028)

Figure 23. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2028)

Figure 24. Europe Gene Therapy on Neurological Diseases Market Size Share by Country (2017-2028)

Figure 25. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific Gene Therapy on Neurological Diseases Market Size Share by Region (2017-2028)

Figure 35. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America Gene Therapy on Neurological Diseases Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2028)

Figure 43. Latin America Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2028)

Figure 44. Latin America Gene Therapy on Neurological Diseases Market Size Share by Country (2017-2028)

Figure 45. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa Gene Therapy on Neurological Diseases Market Size Share by Country (2017-2028)

Figure 51. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE Gene Therapy on Neurological Diseases Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2017-2022)

Figure 55. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2017-2022)

Figure 56. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2017-2022)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-25M7562

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-29P12566

Mon Mar 25 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-11Z11048

Thu Mar 21 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions